UNIV DEBRECEN has a total of 19 patent applications. Its first patent ever was published in 2003. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are OCCLUGEL, QINGDAO CONTINENT PHARM CO LTD and TRICIDA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | Canada | 2 | |
#4 | Australia | 1 | |
#5 | China | 1 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Macromolecular chemistry and polymers | |
#5 | Micro-structure and nano-technology | |
#6 | Chemical engineering |
# | Name | Total Patents |
---|---|---|
#1 | Fesues Laszlo | 5 |
#2 | Korponay-Szabo Ilma | 4 |
#3 | Maeki Markku | 4 |
#4 | Szatmari Istvan | 4 |
#5 | Borbely Janos | 4 |
#6 | Kiraly Robert | 4 |
#7 | Bagossi Peter | 4 |
#8 | Simon-Vecsei Zsofia | 4 |
#9 | Nagy Laszlo | 4 |
#10 | Csosz Eva | 3 |
Publication | Filing date | Title |
---|---|---|
WO2013124700A2 | Composition based on silybum marianum seed oil and process for the preparation of the seed oil | |
WO2009068926A1 | Use of urokinase type plasminogen activator inhibitors for the treatment of corneal disorders | |
WO2007144679A2 | Compounds, kits and methods for conferring cytoprotection | |
US2005226938A1 | Nanoparticles from chitosan | |
EP1509550A2 | Polymeric product for film formation |